EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix

被引:21
作者
Dimmler, Arno [1 ]
Geddert, Helene [1 ]
Faller, Gerhard [1 ]
机构
[1] St Vincents Hosp, Inst Pathol, D-76137 Karlsruhe, Germany
关键词
Goblet cell carcinoid; EGFR; KRAS; BRAF; MSI; Pyrosequencing; GROWTH-FACTOR RECEPTOR; NEUROENDOCRINE TUMORS; GENETIC ALTERATIONS; SOMATIC MUTATIONS; ENDOCRINE TUMORS; CLASSIFICATION; FREQUENT; RARE; RAS;
D O I
10.1016/j.prp.2014.01.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Goblet cell carcinoid (GCC) is a rare type of mixed endocrine-exocrine tumor of the appendix often showing a clinically aggressive behavior. On a molecular basis, this tumor is only poorly understood. To analyze possible molecular similarities between GCC and colorectal cancer, we examined 14 cases of GCC for mutations in exons 18, 19 and 21 of the EGFR-gene, exon 2 in the KRAS gene and for V600E mutations of the BRAF gene. Although the sensitive pyrosequencing method was used, no EGFR, KRAS or BRAF mutations could be found. Furthermore, using immunohistochemistry, no evidence for microsatellite instabillity (MSI) could be found. Despite the partial intestinal differentiation of GCC, our study indicates that the molecular pathogenesis of GCC significantly differs from conventional colorectal adenocarcinoma. This finding might also have implications in adjuvant chemotherapeutic treatment of advanced GCC. (C) 2014 Elsevier GmbH. All rights reserved.
引用
收藏
页码:274 / 278
页数:5
相关论文
共 36 条
[1]   The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis [J].
Ardekani, Gholamreza Safaee ;
Jafarnejad, Seyed Mehdi ;
Tan, Larry ;
Saeedi, Ardavan ;
Li, Gang .
PLOS ONE, 2012, 7 (10)
[2]   Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system [J].
Arnold, Christian N. ;
Sosnowski, Andrea ;
Schmitt-Graeff, Annette ;
Arnold, Rudolf ;
Blum, Hubert E. .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (10) :2157-2164
[3]   Somatic mutations of EGFR in colorectal cancers and glioblastomas [J].
Barber, TD ;
Vogelstein, B ;
Kinzler, KW ;
Velculescu, VE .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2883-2883
[4]   Large-Cell Neuroendocrine Carcinoma of the Lung Harboring EGFR Mutation and Responding to Gefitinib [J].
De Pas, Tommaso M. ;
Giovannini, Monica ;
Manzotti, Michela ;
Trifiro, Giuseppe ;
Toffalorio, Francesca ;
Catania, Chiara ;
Spaggiari, Lorenzo ;
Labianca, Roberto ;
Barberis, Massimo .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (34) :E819-E822
[5]  
Deschamps L, 2010, ARCH PATHOL LAB MED, V134, P871, DOI 10.1043/1543-2165-134.6.871
[6]   Comparative analysis of dideoxy sequencing, the KRAS StripAssay and pyrosequencing for detection of KRAS mutation [J].
Gao, Jing ;
Li, Yan-Yan ;
Sun, Ping-Nai ;
Shen, Lin .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (38) :4858-4864
[7]   Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors [J].
Gilbert, Judith A. ;
Adhikari, Laura J. ;
Lloyd, Ricardo V. ;
Rubin, Joseph ;
Haluska, Paul ;
Carboni, Joan M. ;
Gottardis, Marco M. ;
Ames, Matthew M. .
ENDOCRINE-RELATED CANCER, 2010, 17 (03) :623-636
[8]  
Gospodarowicz MK, 2010, TNM CLASSIFICATION M
[9]   Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR [J].
Heinemann, Volker ;
Stintzing, Sebastian ;
Kirchner, Thomas ;
Boeck, Stefan ;
Jung, Andreas .
CANCER TREATMENT REVIEWS, 2009, 35 (03) :262-271
[10]   Goblet Cell Carcinoids of the Appendix [J].
Holt, Nanna ;
Gronbaek, Henning .
SCIENTIFIC WORLD JOURNAL, 2013,